Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date January 15, 2025

(NASDAQ:NDAQ), NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) — At the end of the settlement date of January 15, 2025, short interest in 3,099 Nasdaq Global MarketSM securities totaled 12,402,417,655 shares compared with 12,137,206,474 shares in 3,085 Global Market issues reported for the prior settlement date of December 31, 2024. The mid-January short interest represents […]

Financial Institutions, Inc. Appoints Angela J. Panzarella to Board of Directors

(NASDAQ:FISI), WARSAW, N.Y., Jan. 27, 2025 (GLOBE NEWSWIRE) — Financial Institutions, Inc. (NASDAQ: FISI) (the “Company”), the parent company of Five Star Bank (the “Bank”) and Courier Capital, LLC, today announced the appointment of Angela J. Panzarella as a new independent member of the Boards of Directors of both the Company and the Bank, on

22nd Century Regains Full Compliance with Nasdaq Continued Listing Standards

(NASDAQ:XXII), MOCKSVILLE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it has received formal written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the

Beyond Air(R) Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

(NASDAQ:XAIR), GARDEN CITY, N.Y., Jan. 27, 2025 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that it plans to report the financial results for the

Medexus Pharmaceuticals Announces Overnight Marketed Public Offering of Common Shares

(TSX:MDP),(Frankfurt:P731), NOT FOR DISTRIBUTION TO UNITED STATES TORONTO and CHICAGO, Jan. 27, 2025 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP), is pleased to announce that it has launched an overnight marketed underwritten offering (the “Offering”) of common shares of the Company (the “Common Shares”). The Offering is expected to be

Sanmina Reports First Quarter Fiscal 2025 Financial Results

Sanmina Corporation (“Sanmina” or the “Company”) (NASDAQ: SANM), a leading integrated manufacturing solutions company, today reported financial results for the first quarter ended December 28, 2024 and outlook for its second fiscal quarter ending March 29, 2025. First Quarter Fiscal 2025 Financial Highlights• Revenue: $2.01 billion• GAAP operating margin: 4.4%• GAAP diluted EPS: $1.16• Non-GAAP(1)

AGNC Investment Corp. Announces Fourth Quarter 2024 Financial Results

AGNC Investment Corp. (“AGNC” or the “Company”) (Nasdaq: AGNC) today announced financial results for the quarter ended December 31, 2024. FOURTH QUARTER 2024 FINANCIAL HIGHLIGHTS — $(0.11) comprehensive loss per common share, comprised of: — $0.10 net income per common share — $(0.20) other comprehensive loss (“OCI”) per common share on investments marked-to-market through OCI

Gamehaus Holdings Inc. Celebrates NASDAQ Listing and Shares Vision for Future Growth

Gamehaus Holdings Inc.(“Gamehaus” or the “Company”) (Nasdaq: GMHS),a technology-driven mobile game publisher, today announced its official listing on the Nasdaq Capital Market (“NASDAQ”). The Company's Class A ordinary shares began trading today under the stock symbol “GMHS,” marking a pivotal step in its continued expansion and commitment to shaping the future of the global gaming

Akero Therapeutics Announces Proposed Public Offering of Common Stock

(NASDAQ:AKRO), SOUTH SAN FRANCISCO, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, announced today that it has commenced an underwritten public offering of $300.0 million of shares of its common stock. All of

Ann Begeman Appointed to CSX Board of Directors

(NASDAQ:CSX), JACKSONVILLE, Fla., Jan. 27, 2025 (GLOBE NEWSWIRE) — CSX Corporation (NASDAQ: CSX) today announced that Ann Begeman has been appointed to the company's board of directors. “Ann brings a wealth of industry expertise and knowledge to our team where she will play a vital role in our commitment to deliver service excellence and business

Scroll to Top